Sources and Prices of Selected Drugs and Diagnostics for People Living with HIV/AIDS (UNAIDS, 2001, 36 p.): Annex IV: Further information and contacts

Sources and Prices of Selected Drugs and Diagnostics for People Living with HIV/AIDS (UNAIDS, 2001, 36 p.)

(introduction...)

Introduction

Background

Supply and prices

Information on sources and prices of selected drugs and diagnostics

1. Antiretroviral drugs

(introduction...)

1.1 Antiretroviral drugs used in prevention of MTCT and included in MEDL (1999)

1.2 Antiretroviral drugs not included in MEDL (1999)

1.3 Donations and price reductions for antiretroviral drugs

2. Drugs used for the treatment of opportunistic infections

2.1 Antibacterial drugs

2.2 Antifungal drugs

2.3 Antiherpes drugs

2.4. Antiprotozoals, antipneumocystosis, and antitoxoplasmosis drugs

3. Drugs used for the treatment of HIV/AIDS-related cancers

4. Drugs for use in palliative care

5. Diagnostics

Annex I: Offers of donation/price reductions of antiretroviral drugs up to 15 April 2001

Annex II: Bulk procurement list for HIV tests

Annex III: Manufacturers per therapeutic group included in the price survey (2000)

Annex IV: Further information and contacts

Annex IV: Further information and contacts

Further reading:

· Access to drugs: UNAIDS Technical Update, UNAIDS, Geneva, 1998.
· HIV-related opportunistic diseases: UNAIDS Technical Update, UNAIDS, Geneva, 1998.
· Standard treatments and essential drugs for HIV-related conditions, WHO, Geneva, (DAP/97.9).
· The Use of Essential Drugs, including the WHO Model List of Essential Drugs (revised 1999). WHO Drug Information, 13(4): 249-262.
· WHO Model prescribing information: Drugs used in HIV-related infections, WHO, Geneva, (WHO/DMP/DSI/99.2).
· Safe and effective use of antiretroviral treatments in adults, with particular reference to resource limited settings (WHO/UNAIDS/International AIDS Society), WHO, Geneva (WHO/HIS/2000.04).
· Guidance Modules on Antiviral Treatments, Module 4. WHO/UNAIDS, Geneva, 1998 (WHO/ASD/98.1 - UNAIDS/98.7).
· Guidelines for Drug Donations (interagency document), WHO, Geneva,1999 (WHO/EDM/PAR/99.4.http://www.who.int/medicines/docs/pagespublications/supplypub.htm).
· Guidelines on interaction with commercial enterprises to achieve health outcomes (Annex to Guidelines on working with the private sector to achieve health outcomes), WHO, Geneva, 2000 (http:/www.who.int/wha-1998/EBWHA/PDF/EB107/ee20.pdf) (EB107/20; 30 November 2000).

Web sites:

UNAIDS: www.unaids.org
UNICEF: www.unicef.org
WHO: www.who.int
MSF: www.accessmed-msf.org

Contacts:

For further information about suppliers or products, contact Technical Services Centre, UNICEF, Supply Division, supply@unicef.dk fax +45 35 269421
For further information on HIV test kit evaluations or the bulk procurement scheme, contact Blood Safety and Clinical Technology (BCT), World Health Organization
Fax +41 22 791 4836

For any comments on this document, or additional information that could be useful to this project, please contact:

Technical Services Centre, UNICEF, Supply Division
Fax: +45 35 269421
Essential Drugs and Medicines Policy (EDM), World Health Organization
Fax: +41 22 7914167
Department of Policy Strategy and Research, UNAIDS
Fax: +41 22 7914741
Campaign for Access to Essential Drugs, MSF
Fax: +41 22 8498404